Phase3, Open-Label, Long-Term, NSAID-Add-on, Clinical Trial of NPC-01 for Treatment of Dysmenorrhea Associated With Endometriosis.
Phase of Trial: Phase III
Latest Information Update: 23 Jul 2014
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Dysmenorrhoea
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 26 Apr 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 26 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2012 Actual patients number is 148 as reported by ClinicalTrials.gov.